| abstract |
The disclosure provides methods of treating liver cancers including hepatocellular carcinoma in a subject in need of treatment, where the methods comprise administration of a compound or a composition or formulation comprising a compound of Formulas (I), (II), (III), (IV), (V), and (VI) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof. |